vs
Ispire Technology Inc.（ISPR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Ispire Technology Inc.的1.8倍（$35.5M vs $20.3M），Ispire Technology Inc.净利率更高（-32.5% vs -304.2%，领先271.7%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -51.5%），Ispire Technology Inc.自由现金流更多（$-4.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -17.8%）
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ISPR vs RXRX — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.3M | $35.5M |
| 净利润 | $-6.6M | $-108.1M |
| 毛利率 | 17.1% | 59.8% |
| 营业利润率 | -33.9% | -304.8% |
| 净利率 | -32.5% | -304.2% |
| 营收同比 | -51.5% | 681.7% |
| 净利润同比 | 17.4% | 39.6% |
| 每股收益（稀释后） | $-0.12 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $20.3M | $35.5M | ||
| Q3 25 | $30.4M | $5.2M | ||
| Q2 25 | $20.1M | $19.2M | ||
| Q1 25 | $26.2M | $14.7M | ||
| Q4 24 | $41.8M | $4.5M | ||
| Q3 24 | $39.3M | $26.1M | ||
| Q2 24 | $37.3M | $14.4M | ||
| Q1 24 | $30.0M | $13.8M |
| Q4 25 | $-6.6M | $-108.1M | ||
| Q3 25 | $-3.3M | $-162.3M | ||
| Q2 25 | $-14.8M | $-171.9M | ||
| Q1 25 | $-10.9M | $-202.5M | ||
| Q4 24 | $-8.0M | $-178.9M | ||
| Q3 24 | $-5.6M | $-95.8M | ||
| Q2 24 | $-3.5M | $-97.5M | ||
| Q1 24 | $-5.9M | $-91.4M |
| Q4 25 | 17.1% | 59.8% | ||
| Q3 25 | 17.0% | -183.8% | ||
| Q2 25 | 12.3% | -4.9% | ||
| Q1 25 | 18.2% | -48.0% | ||
| Q4 24 | 18.5% | -181.4% | ||
| Q3 24 | 19.5% | 53.7% | ||
| Q2 24 | 28.3% | 36.2% | ||
| Q1 24 | 20.4% | 19.1% |
| Q4 25 | -33.9% | -304.8% | ||
| Q3 25 | -8.9% | -3327.6% | ||
| Q2 25 | -72.7% | -916.8% | ||
| Q1 25 | -40.4% | -1297.9% | ||
| Q4 24 | -17.6% | -4042.4% | ||
| Q3 24 | -13.4% | -377.1% | ||
| Q2 24 | -9.2% | -697.4% | ||
| Q1 24 | -18.8% | -698.4% |
| Q4 25 | -32.5% | -304.2% | ||
| Q3 25 | -10.7% | -3135.3% | ||
| Q2 25 | -73.4% | -894.2% | ||
| Q1 25 | -41.5% | -1373.3% | ||
| Q4 24 | -19.1% | -3935.5% | ||
| Q3 24 | -14.2% | -367.5% | ||
| Q2 24 | -9.4% | -676.6% | ||
| Q1 24 | -19.7% | -662.4% |
| Q4 25 | $-0.12 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | $-0.26 | $-0.41 | ||
| Q1 25 | $-0.19 | $-0.50 | ||
| Q4 24 | $-0.14 | $-0.56 | ||
| Q3 24 | $-0.10 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.40 | ||
| Q1 24 | $-0.11 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-7.7M | $1.1B |
| 总资产 | $84.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $17.6M | $743.3M | ||
| Q3 25 | $22.7M | $659.8M | ||
| Q2 25 | $24.4M | $525.1M | ||
| Q1 25 | $23.5M | $500.5M | ||
| Q4 24 | $34.4M | $594.4M | ||
| Q3 24 | $37.7M | $427.6M | ||
| Q2 24 | $35.1M | $474.3M | ||
| Q1 24 | $39.5M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $-7.7M | $1.1B | ||
| Q3 25 | $-1.8M | $1.0B | ||
| Q2 25 | $604.7K | $919.1M | ||
| Q1 25 | $14.8M | $933.9M | ||
| Q4 24 | $24.2M | $1.0B | ||
| Q3 24 | $30.7M | $524.6M | ||
| Q2 24 | $34.5M | $584.4M | ||
| Q1 24 | $35.9M | $401.2M |
| Q4 25 | $84.4M | $1.5B | ||
| Q3 25 | $96.4M | $1.4B | ||
| Q2 25 | $102.2M | $1.3B | ||
| Q1 25 | $115.7M | $1.3B | ||
| Q4 24 | $132.0M | $1.4B | ||
| Q3 24 | $129.0M | $726.5M | ||
| Q2 24 | $122.6M | $775.9M | ||
| Q1 24 | $108.0M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | -19.9% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-4.0M | $-46.1M | ||
| Q3 25 | $-1.2M | $-117.4M | ||
| Q2 25 | $4.7M | $-76.4M | ||
| Q1 25 | $-12.5M | $-132.0M | ||
| Q4 24 | $-3.2M | $-115.4M | ||
| Q3 24 | $3.6M | $-59.2M | ||
| Q2 24 | $-1.4M | $-82.2M | ||
| Q1 24 | $3.4M | $-102.3M |
| Q4 25 | $-4.0M | $-47.3M | ||
| Q3 25 | $-1.2M | $-117.6M | ||
| Q2 25 | $3.7M | $-79.6M | ||
| Q1 25 | $-12.7M | $-133.8M | ||
| Q4 24 | $-3.2M | $-116.7M | ||
| Q3 24 | $3.3M | $-63.8M | ||
| Q2 24 | $-2.2M | $-83.4M | ||
| Q1 24 | $3.3M | $-109.0M |
| Q4 25 | -19.9% | -133.1% | ||
| Q3 25 | -3.9% | -2272.5% | ||
| Q2 25 | 18.6% | -413.9% | ||
| Q1 25 | -48.4% | -907.4% | ||
| Q4 24 | -7.7% | -2567.7% | ||
| Q3 24 | 8.5% | -244.6% | ||
| Q2 24 | -5.9% | -578.5% | ||
| Q1 24 | 10.9% | -789.9% |
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 4.8% | 16.4% | ||
| Q1 25 | 0.7% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 2.0% | 8.2% | ||
| Q1 24 | 0.3% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
